MyFinsight
Home
Blog
About
Contact
Accounts receivable
-$2,682,802
Depreciation and
amortization expense
$1,276,283
Inventories, net
-$703,861
Other current assets
and other assets
-$384,152
Amortization of operating
lease right-of-use...
$285,184
Decrease in cash
surrender value of life...
-$218,916
Co-commercialization investment loss
-$146,080
Share-based compensation
$106,842
Noncash interest
expense
$5,173
Net cash provided by
operating activities
$387,025
Canceled cashflow
$5,422,268
Net decrease in cash
and cash...
-$437,448
Canceled cashflow
$387,025
Net (loss) income
-$3,287,051
Accounts payable and
other current...
-$1,346,113
Increase (decrease) in
non-cash contingent...
-$228,965
Operating lease
liabilities
-$225,351
Other long-term
liabilities
-$202,821
something is missing
-$131,967
Net cash used in
financing activities
-$763,300
Net cash provided by
(used in) investing...
-$61,173
Cash settlement of
contingent consideration
$702,299
Payments made in
connection with repurchase...
$61,001
Increase in cash
surrender value of life...
$42,018
Additions to intangible
assets
$19,155
Back
Back
Cash Flow
CUMBERLAND PHARMACEUTICALS INC (CPIX)
CUMBERLAND PHARMACEUTICALS INC (CPIX)
source: myfinsight.com